bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the appointment of Stefan Willemsen as President and CEO of bioMérieux Inc.
Asia
Europe, Middle East, Africa
North America
The General Shareholders' Meeting of bioMérieux Approves the Appointment of Two New Independent Directors
28 May, 2014
The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent directors, Agnès Lemarchand and Philippe Gillet.
ASM 2014 - bioMérieux is Pioneering Diagnostics to Fight Antibiotic Resistance
19 May, 2014
Amid the growing global threat from antibiotic resistant organisms, bioMérieux is leveraging its robust history of fighting infectious diseases to provide solutions and services that aid Antibiotic Stewardship Programs.
BioFire's FilmArray® Gastrointestinal Panel Receives FDA Clearance
05 May, 2014
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its new molecular biology affiliate, received U.S. Food and Drug Administration (FDA) 510(k) clearance for the FilmArray® Gastrointestinal (GI) Panel1.
First-Quarter 2014 Business Review
23 April, 2014
Alexandre Mérieux Assumes Role of bioMérieux CEO
15 April, 2014
Alexandre Mérieux will take on the role of Chief Executive Officer of bioMérieux and head its Management Committee. To step up the rollout of its strategic plan, a new organization is being deployed.
bioMérieux Educates Future Microbiologists at the Triangle SciTech Expo
05 April, 2014
bioMérieux participated at the Triangle SciTech Expo by creating a fun and educational exhibit exposing youth to the microbiology field at the North Carolina Museum of Natural Sciences in Raleigh, NC.
bioMérieux 2013 Financial Results
20 March, 2014
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met yesterday and approved the consolidated financial statements for the year ended December 31, 2013.
bioMérieux Strengthens its Clostridium difficile Offer with the Launch of VIDAS® C. difficile GDH
26 February, 2014
VIDAS® C. difficile GDH is the 100th assay for use on VIDAS® range VIDAS® C. difficile GDH is the only FDA-approved automated immunoassay parameter for GDH* detection * Glutamate dehydrogenase
BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel
19 February, 2014
BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance.